MedPath

Cancer survivor as patient navigator

Phase 3
Conditions
Health Condition 1: C01- Malignant neoplasm of base of tongueHealth Condition 2: C32- Malignant neoplasm of larynxHealth Condition 3: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Registration Number
CTRI/2021/12/038845
Lead Sponsor
Conquer Cancer Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All patients with locally advanced head and neck cancer planned for radical CRT

2.Age >18 years

Exclusion Criteria

1.Patients unwilling to be a part of the study

2.Patients unfit for radical chemoradiation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To determine and compare the quality of life in both groups. <br/ ><br>Quality of life in these patients will be assessed using the EORTC QLQ C30 & QLQ H&N35 both groupsTimepoint: 0, 4 weeks, treatment completion, 2 months post treatment
Secondary Outcome Measures
NameTimeMethod
1.To determine and compare the treatment interruptions in both groupsTimepoint: Through out treatment;2.To determine and compare the acute toxicity in both arms.Timepoint: Through out treatment;To determine and compare patient satisfaction among both groupsTimepoint: At treatment completion;To determine and compare the treatment dropouts in both groupsTimepoint: Through out treatment
© Copyright 2025. All Rights Reserved by MedPath